Nous informons les visiteurs que ce site Internet est, uniquement, à destination des professionnels de santé (*)
Merci de confirmer que vous êtes un professionnel de santé (*)

Oui, je reconnais être un professionnel de santé (*)  Non, je ne suis pas un professionnel de santé (*)

(*) Un professionnel de santé est défini comme toute personne habilitée à prescrire, dispenser ou utiliser des DMDIV (Dispositifs Médicaux de Diagnostic In Vitro) dans l’exercice de son art.


Cette page est réservée aux professionnels. Ils ne sont pas autorisés.

Assistance à distance

GoToAssist est un service de télémaintenance qui permet à nos équipes d’intervenir à distance sur vos analyseurs.
Pour vous connecter, veuillez cliquer sur le lien suivant : Assistance à distance

OncoBEAMTM EGFR Kit (RUO) at Jessenius Medical Faculty of Comenius University and its University Hospital, in Martin, Slovakia.

The launch is the first of its kind and will widen the use of of BEAMing technology in lung cancer area.

Date : 2017-10-03 Balises: Español, Press release, España

Hamburg, Germany, 2017.09.25 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, announces that the OncoBEAM™ EGFR Kit (RUO) is now available in Slovakia’s leading medical institution, Jessenius Medical Faculty of Comenius University and its Department of Pathology in University Hospital, Martin, led by renowned Professor Plank.

The OncoBEAM™ EGFR Kit (RUO) is designed to utilize the BEAMing technology platform which is installed globally at hospital laboratories and is widely used to perform RAS mutation detection for colorectal cancer patients with the OncoBEAM™ RAS CRC Kit. BEAMing digital PCR technology employs beads-based amplification in water-in-oil emulsions and allele-specific hybridization followed by flow cytometry. The OncoBEAM™ EGFR Kit (RUO) is a Research Use Only assay for the qualitative detection of EGFR mutations (exon 19, 20 and 21) including T790M in cell-free DNA extracted from plasma. The OncoBEAM™ EGFR Kit (RUO) represents a new standard for the highly sensitive detection of EGFR mutations including sensitizing mutations such as Exon 19 deletions and L858R and the primary EGFR resistance mutations, T790M and C797S.

Professor Lukas Plank remarked, “we are honored that, through our joint-venture with Martin´s Biopsy Center Ltd. and after the start with a pilot clinical study using OncoBEAM™ RAS CRC Kit, we now have the privilege to examine plasma EGFR mutations in our lung cancer program with the support of a superb methodology demonstrating high sensitivity and unsurpassed by previously used assays. I am strongly convinced that these tests will substantially contribute to the progress in oncological care of our patients, at the same moment I am deeply proud of the collaboration and proficiency showed by all members of our team.”

“This introduction of OncoBEAM™ EGFR (RUO) signals further progress of the contributions BEAMing digital PCR technology continues to make for the oncology field, and I am proud it is serving to improve Slovakia’s management and molecular understanding of lung cancer,” Mark Kubota, CEO of Sysmex Inostics noted. “Lung cancer is one of the most prevalent cancers in the world, and the high sensitivity of the BEAMing technology can deliver a powerful tool to understand the dynamics of plasma EGFR mutational profiles in relation to lung cancer.” Sysmex Inostics plans to offer the OncoBEAM™ EGFR Kit (RUO) to other European and Asian countries.



Retour à la liste
Voir l’évolutivité du XN
Voir les caractéristiques
Découvrez notre galerie des médias
  • Tous
  • Documents
  • Podcast
  • Images
  • Vidéos
Venez visionner le film
Voir notre bibliothèque
Voir notre bibliothèque
Voir notre bibliothèque
Voir notre bibliothèque de frottis
En savoir plus sur ce concept
Visionner le film
Marathon de Rotterdam 2015